Literature DB >> 30280421

Cutaneous hyperpigmentation and familial gastrointestinal stromal tumour associated with KIT mutation.

G N Wali1, D Halliday2, J Dua1, E Ieremia3, T McPherson1, R N Matin1.   

Abstract

Gastrointestinal stromal tumours (GISTs) are mesenchymal tumours arising in the gastrointestinal tract. Early detection, before metastasis occurs, is important as complete surgical excision achieves cure. Approximately 85% of GISTs are associated with mutations in the KIT gene, and although the majority of GISTs are sporadic, familial GISTs have been identified. Several families with multiple GIST tumours have also been described with various cutaneous findings including hyperpigmentation, multiple lentigines, vitiligo and urticaria pigmentosa. We discuss a 6-year-old boy who presented with an unusual pattern of hyperpigmentation in association with a family history of GIST. A causative KIT mutation was identified in DNA from the pigmented skin and from the resected GIST, and the patient was referred to the Paediatric Gastroenterology department for GIST screening. The term 'GIST cutaneous hyperpigmentation disease' has been suggested previously for the association of familial GIST with cutaneous hyperpigmentation caused by a germline KIT mutation.
© 2018 British Association of Dermatologists.

Entities:  

Year:  2018        PMID: 30280421     DOI: 10.1111/ced.13757

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

1.  Case Report: A Missense Mutation of KIT in Hyperpigmentation and Lentigines Unassociated With Systemic Disorders: Report of a Chinese Pedigree and a Literature Review.

Authors:  Lu Yang; Yuehua Liu; Tao Wang
Journal:  Front Med (Lausanne)       Date:  2022-05-25

2.  Familial gastrointestinal stromal tumors with KIT germline mutation in a Chinese family: A case report.

Authors:  Wei Yuan; Wen Huang; Lei Ren; Chen Xu; Li-Juan Luan; Jie Huang; An-Wei Xue; Yong Fang; Xiao-Dong Gao; Kun-Tang Shen; Jing-Huan Lv; Ying-Yong Hou
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

3.  KIT-Associated Familial GIST Syndrome: Response to Tyrosine Kinase Inhibitors and Implications for Risk Management.

Authors:  Alexandra Brodey; Valentinos Kounnis; Lara Hawkes; Robin L Jones; Terri P McVeigh; Elena Cojocaru
Journal:  Oncologist       Date:  2022-08-05       Impact factor: 5.837

4.  A Novel Kindred with Familial Gastrointestinal Stromal Tumors Caused by a Rare KIT Germline Mutation (N655K): Clinico-Pathological Presentation and TKI Sensitivity.

Authors:  Mara Fornasarig; Daniela Gasparotto; Luisa Foltran; Michele Campigotto; Sara Lombardi; Elisa Del Savio; Angela Buonadonna; Fabio Puglisi; Sandro Sulfaro; Vincenzo Canzonieri; Renato Cannizzaro; Roberta Maestro
Journal:  J Pers Med       Date:  2020-11-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.